Best online tirzepatide for cash pay
What to look for, and the program we pick for this need.
Released: · Last reviewed:
Paying cash, our pick is NexLife: $129 month to month or $115 a month on a 12-month plan, the same at every dose, with FSA/HSA, Klarna and Afterpay accepted on its plan pages (as of November 6, 2026); Zepbound self-pay through Lilly costs $299 to $449 a month.
Lower all-in figures in our index need a membership, a sale or a prepaid plan. Compounded tirzepatide is not FDA-approved.
Cash prices month to month
| Program | Month to month | Terms as printed | Read |
|---|---|---|---|
| SnagRx | $119 | sale price (was $349); all sales final | October 15, 2026 |
| NextMeds | $119 | "from", same price every month; plan term not printed | October 15, 2026 |
| yourEra | $123 | "as low as" | October 15, 2026 |
| Mondae | $126 | 1 month; $124 on 3 months, $114 on 6 months prepaid | October 15, 2026 |
| NexLife | $129 | month to month; $125 / $119 / $115 on 3 / 6 / 12 months; same at every dose | November 6, 2026 |
| Eden | $129 | every month, no membership | October 15, 2026 |
| CoreAge Rx | $129 | "starting at", no membership fees | October 15, 2026 |
| Embody | $129 | sale (regular $349); $119 a month on a $1,428 prepaid year | October 15, 2026 |
| Strut Health | $149 | "as low as", 30-day supply on auto-refill | October 15, 2026 |
Zepbound self-pay
| Dose | Refill within 45 days | Later refill |
|---|---|---|
| 2.5 mg | $299 | $299 |
| 5 mg | $399 | $399 |
| 7.5 mg | $449 | $499 |
| 10 mg | $449 | $699 |
| 12.5 mg | $449 | $699 |
| 15 mg | $449 | $699 |
NexLife
$129 month to month, or $115 a month on a 12-month plan ($1,380 a year), the same price at every dose, with no membership (as of November 6, 2026). Plans of 3 and 6 months are $125 and $119 a month.
Included, per NexLife's plan pages: provider review and medical guidance (NexLife Medical Group), a personalized nutrition plan, a 1:1 call with a wellness coach, 24/7 support and free expedited shipping. The plan pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA).
Not the lowest price we track. Compounded tirzepatide is not FDA-approved; a licensed clinician decides whether it is right for you.
See NexLife's current plans → Read the reviewQuestions readers ask
Does insurance cover compounded tirzepatide?
Generally no. Compounded tirzepatide is cash-pay, though many programs accept HSA or FSA cards, and NexLife's plan pages list FSA/HSA. Brand-name Zepbound may be covered by a commercial plan, and the Medicare GLP-1 Bridge charges eligible Part D enrollees $50 a month for the Zepbound KwikPen only, through December 31, 2027.
Is NexLife the cheapest option?
No. As of November 6, 2026, NexLife charges $129 month to month and $115 a month on a 12-month plan. In our index, Collective (with its yearly membership), WellMedr (on sale) and Mondae (prepaid 6 months) show lower all-in figures, and Eden matches NexLife's $129 month to month. We rank NexLife first on our full methodology, not on price alone.
Is compounded tirzepatide cheaper than Zepbound?
Usually, per month. Zepbound self-pay through Lilly is $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg to 15 mg with on-time refills, while the programs in our index run about $86 to $280 a month all-in. Compounded tirzepatide is not FDA-approved and is not the same product as Zepbound.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness or quality before they are sold. It is made with the drug in Zepbound and Mounjaro, but it is not the same product. Lilly's Zepbound and Mounjaro are the FDA-approved tirzepatide medicines.
Sources
- NexLife, compounded tirzepatide plans, read November 6, 2026.
- Eden, GLP-1 weight loss pricing, read October 15, 2026.
- Collective, holistic weight loss pricing, read October 15, 2026.
- Emerge Weight Loss, pricing, read October 15, 2026.
- Eli Lilly, Zepbound coverage and self-pay savings, read October 15, 2026.
- FDA, Concerns with unapproved GLP-1 drugs used for weight loss, page current as of October 1, 2026.
Full program list with links: price index and the open dataset tirzepatide-price-index.json (CC BY 4.0).